Across
- 3. LCD: Local _______ Determinants
- 4. AJCC: American _______ Committee on Cancer
- 6. ACRIN: American _____ of Radiology Imaging Network
- 8. SAR: ______ Adverse Reaction
- 9. CORE:Cancer _____Research and Education
- 12. CTEP: Cancer Therapy ________ Program
- 13. MTD: Maximum _______ Dose
- 17. IDE: Investigational Device _____
Down
- 1. NCD: _____ Coverage Determinants
- 2. ECOG: Eastern _______ Oncology Group
- 5. NCCN: National _______ Cancer Network
- 7. CRF: Case ______ Form
- 10. CTCAE: Common ______ Criteria for Adverse EventsAsset AMS: _____ Management Services
- 11. IB: Investigator ________
- 14. CTC: Common _______ Criteria
- 15. IND: Investigational _____ Drug
- 16. AESI: Adverse Event of _____ Interest